Skip to main content

Advertisement

Log in

Steroid resistance in asthma: Mechanisms and treatment options

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Glucocorticoid insensitivity presents a profound management problem in patients with asthma because conventional therapies are not effective. Glucocorticoids, acting through the glucocorticoid receptor (GR), are able to selectively repress inflammatory gene expression by utilizing several distinct mechanisms targeting nuclear factor-κB and activator protein-1 activation complexes and by effects on mitogen-activated protein kinases. Different model systems often activate distinct sets of signaling molecules and different glucocorticoid responsiveness may result from differences in concentrations and timing of steroid treatment of cells, GR expression levels, and the precise inflammatory stimulus used. Thus, abnormal activation of many signaling pathways may affect corticosteroid responsiveness in patients with corticosteroid-resistant asthma. Understanding the molecular mechanisms of GR action and inaction may lead to the development of new anti-inflammatory drugs or enable clinicians to reverse the relative steroid-insensitivity that is characteristic of some patients with severe asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ito K, Chung KF, Adcock IM: Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006, 117:522–543.

    Article  PubMed  CAS  Google Scholar 

  2. Sont JK, Willems LN, Bel EH, et al.: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043–1051.

    PubMed  CAS  Google Scholar 

  3. Schwartz HJ, Lowell FC, Melby JC: Steroid resistance in bronchial asthma. Ann Intern Med 1968, 69:493–499.

    PubMed  CAS  Google Scholar 

  4. Carmichael J, Paterson IC, Diaz P, et al.: Corticosteroid resistance in chronic asthma. Br Med J 1981, 282:1419–1422.

    Article  CAS  Google Scholar 

  5. Chanez P, Wenzel SE, Anderson GP, et al.: Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007, 119:1337–1348.

    Article  PubMed  Google Scholar 

  6. Moore WC, Bleecker ER, Curran-Everett D, et al.: Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:405–413.

    Article  PubMed  Google Scholar 

  7. Wenzel SE, Busse WW: Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:14–21.

    Article  PubMed  Google Scholar 

  8. Cohen L, EX, Tarsi J, et al.: Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med 2007, 176:138–145.

    Article  PubMed  CAS  Google Scholar 

  9. Bourdin A, Neveu D, Vachier I, et al.: Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007, 119:1367–1374.

    Article  PubMed  Google Scholar 

  10. Goleva E, Hauk PJ, Boguniewicz J, et al.: Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol 2007, 120:1065–1072.

    Article  PubMed  Google Scholar 

  11. Dragonieri S, Schot R, Mertens BJ, et al.: An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007, 120:856–862.

    Article  PubMed  Google Scholar 

  12. Goleva E, Li LB, Eves PT, et al.: Increased glucocorticoid receptor beta alters steroid response in glucocorticoid insensitive asthma. Am J Respir Crit Care Med 2006, 173:607–616.

    Article  PubMed  CAS  Google Scholar 

  13. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, et al.: Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol 2007, 27:2266–2282.

    Article  PubMed  CAS  Google Scholar 

  14. Hew M, Bhavsar P, Torrego A, et al.: Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174:134–141.

    Article  PubMed  CAS  Google Scholar 

  15. Seki Y, Inoue H, Nagata N, et al.: SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med 2003, 9:1047–1054.

    Article  PubMed  CAS  Google Scholar 

  16. Hamilton LM, Puddicombe SM, Dearman RJ, et al.: Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J 2005, 25:978–985.

    Article  PubMed  CAS  Google Scholar 

  17. Weigel NL, Moore NL: Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 2007, 21:2311–2319.

    Article  PubMed  CAS  Google Scholar 

  18. Silkoff PE, Lent AM, Busacker AA, et al.: Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005, 116:1249–1255.

    Article  PubMed  CAS  Google Scholar 

  19. Adcock IM, Lane SJ: Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol 2003, 178:347–355.

    Article  PubMed  CAS  Google Scholar 

  20. Loke TK, Mallett KH, Ratoff J, et al.: Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J Allergy Clin Immunol 2006, 118:368–375.

    Article  PubMed  CAS  Google Scholar 

  21. Vardimon L, Ben-Dror I, Oren A, Polak P: Cytoskeletal and cell contact control of the glucocorticoid pathway. Mol Cell Endocrinol 2006, 252:142–147.

    Article  PubMed  CAS  Google Scholar 

  22. Vasavda N, Eichholtz T, Takahashi A, et al.: Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma. J Allergy Clin Immunol 2006, 118:1090–1096.

    Article  PubMed  CAS  Google Scholar 

  23. Abraham SM, Lawrence T, Kleiman A, et al.: Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 2006, 203:1883–1889.

    Article  PubMed  CAS  Google Scholar 

  24. Ito K, Yamamura S, Essilfie-Quaye S, et al.: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006, 203:7–13.

    Article  PubMed  CAS  Google Scholar 

  25. Trotter KW, Archer TK: Nuclear receptors and chromatine remodeling machinery. Mol Cell Endocrinol 2007, 265–266:162–167.

    Article  PubMed  CAS  Google Scholar 

  26. Bilodeau S, Vallette-Kasic S, Gauthier Y, et al.: Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 2006, 20:2871–2886.

    Article  PubMed  CAS  Google Scholar 

  27. Xystrakis E, Kusumakar S, Boswell S, et al.: Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006, 116:146–155.

    Article  PubMed  CAS  Google Scholar 

  28. Chaudhuri R, Livingston E, McMahon AD, et al.: Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006, 174:127–133.

    Article  PubMed  CAS  Google Scholar 

  29. Livingston E, Darroch CE, Chaudhuri R, et al.: Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004, 114:1475–1478.

    Article  PubMed  CAS  Google Scholar 

  30. Rahman I, Adcock IM: Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006, 28:219–242.

    Article  PubMed  CAS  Google Scholar 

  31. Cookson W, Moffatt M: Making sense of asthma genes. N Engl J Med 2004, 351:1794–1796.

    Article  PubMed  CAS  Google Scholar 

  32. Foley SC, Mogas AK, Olivenstein R, et al.: Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol 2007, 119:863–871.

    Article  PubMed  CAS  Google Scholar 

  33. Wenzel SE, Balzar S, Ampleford E, et al.: IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 2007, 175:570–576.

    Article  PubMed  CAS  Google Scholar 

  34. Hakonarson H, Bjornsdottir US, Halapi, E et al.: Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci U S A 2005, 102:14789–14794.

    Article  PubMed  CAS  Google Scholar 

  35. Salari K, Choudhry S, Tang H, et al.: Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol 2005, 29:76–86.

    Article  PubMed  Google Scholar 

  36. Bellattato C, Adcock IM, Ito K, et al.: Rhinovirus infection reduces glucocorticoid receptor nuclear translocation in airway epithelial cells. Eur Respir J 2003, 22:565S.

    Google Scholar 

  37. Bel E, ten Brinke A: A rational approach to the management of severe refractory asthma. Treat Respir Med 2005, 4:365–379.

    Article  PubMed  Google Scholar 

  38. Goecke IA, Alvarez C, Henriquez J, et al.: Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Mol Immunol 2007, 44:2115–2123.

    Article  PubMed  CAS  Google Scholar 

  39. ten Brinke A, Sterk PJ, Masclee AA, et al.: Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005, 26:812–818.

    Article  PubMed  Google Scholar 

  40. Sullivan SD, Wenzel SE, Bresnahan BW, et al.: Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 2007, 62:655–660.

    Article  PubMed  CAS  Google Scholar 

  41. Szefler S, Rohatagi S, Williams J, et al.: Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma. Chest 2005, 128:1104–1114.

    Article  PubMed  CAS  Google Scholar 

  42. Bateman ED, Linnhof AE, Homik L, et al.: Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Pulm Pharmacol Ther 2007, Epub ahead of print.

  43. Usmani OS, Biddiscombe MF, Barnes PJ: Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med 2005, 172:1497–1504.

    Article  PubMed  Google Scholar 

  44. Barnes PJ: New drugs for asthma. Nat Rev Drug Discov 2004, 3:831–844.

    Article  PubMed  CAS  Google Scholar 

  45. Wu AC, Paltiel AD, Kuntz KM, et al.: Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol 2007, 120:1146–1152.

    Article  PubMed  CAS  Google Scholar 

  46. Adcock IM, Chung KF, Caramori G, Ito K: Kinase inhibitors and airway inflammation. Eur J Pharmacol 2006, 533:118–132.

    Article  PubMed  CAS  Google Scholar 

  47. Comhair SA, Ricci KS, Arroliga M, et al.: Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 2005, 172:306–313.

    Article  PubMed  Google Scholar 

  48. Kharitonov SA, Barnes PJ: Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc. Am Thorac Soc 2004, 1:191–199.

    Article  PubMed  CAS  Google Scholar 

  49. Simon HU: Cytokine and anti-cytokine therapy for asthma. Curr Allergy Asthma Rep 2006, 6:117–121.

    Article  PubMed  CAS  Google Scholar 

  50. Mann BS, Chung KF: Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir Res 2006, 7:59.

    Article  PubMed  CAS  Google Scholar 

  51. Qiu Y, Zhu J, Bandi V, et al.: Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007, 62:475–482.

    Article  PubMed  Google Scholar 

  52. Simpson JL, Powell H, Boyle MJ, et al.: Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2007, Epub ahead of print.

  53. Jayaram L, Duong M, Pizzichini MM, et al.: Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. Eur Respir J 2005, 25:41–46.

    Article  PubMed  CAS  Google Scholar 

  54. Celik GE, Erkekol FO, Miotasiotarliotagil Z, Melli M: Lipoxin A(4) levels in asthma: relation with disease severity and aspirin sensitivity. Clin Exp Allergy 2007, 37:1494–1501.

    PubMed  CAS  Google Scholar 

  55. Berry MA, Hargadon B, Shelley M, et al.: Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006, 354:697–708.

    Article  PubMed  CAS  Google Scholar 

  56. Howarth PH, Babu KS, Arshad HS, et al.: Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005, 60:1012–1018.

    Article  PubMed  CAS  Google Scholar 

  57. Cox G, Thomson NC, Rubin AS, et al.: Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007, 356:1327–1337.

    Article  PubMed  CAS  Google Scholar 

  58. Pavord ID, Cox G, Thomson NC, et al.: Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007, 176:1185–1191.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian M. Adcock.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adcock, I.M., Ford, P.A., Bhavsar, P. et al. Steroid resistance in asthma: Mechanisms and treatment options. Curr Allergy Asthma Rep 8, 171–178 (2008). https://doi.org/10.1007/s11882-008-0028-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-008-0028-4

Keywords

Navigation